S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17

CVS Health (CVS) Stock Forecast, Price & News

+0.83 (+0.84%)
(As of 05/17/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
4.15 million shs
Average Volume
6.35 million shs
Market Capitalization
$130.32 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS Health and its competitors with MarketBeat's FREE daily newsletter.

CVS Health logo

About CVS Health

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.


See More Headlines

Industry, Sector and Symbol

Drug stores & proprietary stores
Drug Retail
Year Founded

Sales & Book Value

Annual Sales
$292.11 billion
Cash Flow
$12.44 per share
Book Value
$57.10 per share


Net Income
$7.91 billion
Pretax Margin




Outstanding Shares
Free Float
Market Cap
$130.32 billion

Company Calendar

Ex-Dividend for 5/2 Dividend
Dividend Payable
Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Social Links


Overall MarketRank

2.73 out of 5 stars

Retail/Wholesale Sector

64th out of 284 stocks

Drug Stores & Proprietary Stores Industry

2nd out of 9 stocks

Analyst Opinion: 2.4Community Rank: 5.0Dividend Strength: 2.5Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -

CVS Health (NYSE:CVS) Frequently Asked Questions

Is CVS Health a buy right now?

19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last twelve months. There are currently 4 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CVS Health stock.
View analyst ratings for CVS Health
or view top-rated stocks.

When is CVS Health's next earnings date?

CVS Health is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for CVS Health

How were CVS Health's earnings last quarter?

CVS Health Co. (NYSE:CVS) announced its quarterly earnings results on Wednesday, May, 4th. The pharmacy operator reported $2.22 EPS for the quarter, topping analysts' consensus estimates of $2.14 by $0.08. The pharmacy operator had revenue of $76.83 billion for the quarter, compared to the consensus estimate of $75.30 billion. CVS Health had a net margin of 2.67% and a trailing twelve-month return on equity of 15.33%. CVS Health's revenue for the quarter was up 11.2% on a year-over-year basis. During the same period last year, the company earned $2.04 EPS.
View CVS Health's earnings history

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health announced a quarterly dividend on Wednesday, March 9th. Investors of record on Friday, April 22nd will be paid a dividend of $0.55 per share on Monday, May 2nd. This represents a $2.20 annualized dividend and a yield of 2.21%. The ex-dividend date of this dividend is Thursday, April 21st.
View CVS Health's dividend history

Is CVS Health a good dividend stock?

CVS Health pays an annual dividend of $2.20 per share and currently has a dividend yield of 2.23%. CVS Health does not yet have a strong track record of dividend growth. The dividend payout ratio of CVS Health is 36.54%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CVS Health will have a dividend payout ratio of 24.26% next year. This indicates that CVS Health will be able to sustain or increase its dividend.
View CVS Health's dividend history.

What guidance has CVS Health issued on next quarter's earnings?

CVS Health issued an update on its FY 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share guidance of $8.20-$8.40 for the period, compared to the consensus EPS estimate of $8.27. The company issued revenue guidance of -.

What price target have analysts set for CVS?

19 Wall Street analysts have issued 12 month target prices for CVS Health's shares. Their forecasts range from $93.00 to $125.00. On average, they expect CVS Health's stock price to reach $115.44 in the next year. This suggests a possible upside of 16.2% from the stock's current price.
View analysts' price targets for CVS Health
or view top-rated stocks among Wall Street analysts.

Who are CVS Health's key executives?
CVS Health's management team includes the following people:
  • Ms. Karen Sue Lynch, Pres, CEO & Director (Age 59, Pay $7.39M)
  • Mr. Shawn Michael Guertin, Exec. VP & CFO (Age 58, Pay $4.34M)
  • Mr. Jonathan C. Roberts, Exec. VP & COO (Age 66, Pay $5.35M) (LinkedIn Profile)
  • Dr. Alan M. Lotvin, Exec. VP & Pres of CVS Caremark (Age 60, Pay $4.01M) (LinkedIn Profile)
  • Mr. James David Clark, Sr. VP, Controller & Chief Accounting Officer (Age 57) (LinkedIn Profile)
  • Ms. Susan V. Lisa, Sr. VP of Investor Relations
  • Mr. Thomas Michael Moriarty, Exec. VP, Chief Policy & External Affairs Officer and Gen. Counsel (Age 58)
  • Mr. David A. Falkowski, Exec. VP & Chief Compliance Officer
  • Mr. Norman de Greve, Chief Marketing Officer
  • Ms. Laurie P. Havanec, Exec. VP & Chief People Officer (Age 61)
What is Larry J. Merlo's approval rating as CVS Health's CEO?

6,978 employees have rated CVS Health CEO Larry J. Merlo on Glassdoor.com. Larry J. Merlo has an approval rating of 37% among CVS Health's employees. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of CVS Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Johnson & Johnson (JNJ), NVIDIA (NVDA), Cisco Systems (CSCO), AbbVie (ABBV), Verizon Communications (VZ), Intel (INTC), Alibaba Group (BABA) and Home Depot (HD).

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

Who are CVS Health's major shareholders?

CVS Health's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.53%), BlackRock Inc. (7.09%), State Street Corp (4.52%), Invesco Ltd. (1.32%), Bank of New York Mellon Corp (1.22%) and Veritas Asset Management LLP (1.12%). Company insiders that own CVS Health stock include Alan Lotvin, Daniel P Finke, Edward J Ludwig, Eva C Boratto, James David Clark, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Prem S Shah, Thomas M Moriarty and Troyen A Brennan.
View institutional ownership trends for CVS Health

Which major investors are selling CVS Health stock?

CVS stock was sold by a variety of institutional investors in the last quarter, including Nordea Investment Management AB, Caisse DE Depot ET Placement DU Quebec, Wellington Management Group LLP, Bank of Montreal Can, State of Michigan Retirement System, Healthcare of Ontario Pension Plan Trust Fund, UBS Group AG, and Canada Pension Plan Investment Board. Company insiders that have sold CVS Health company stock in the last year include Alan Lotvin, Daniel P Finke, James David Clark, Jonathan C Roberts, Prem S Shah, and Troyen A Brennan.
View insider buying and selling activity for CVS Health
or view top insider-selling stocks.

Which major investors are buying CVS Health stock?

CVS stock was purchased by a variety of institutional investors in the last quarter, including Vanguard Group Inc., State Street Corp, Bank of New York Mellon Corp, Eaton Vance Management, American Century Companies Inc., Swiss National Bank, KBC Group NV, and Arrowstreet Capital Limited Partnership.
View insider buying and selling activity for CVS Health
or or view top insider-buying stocks.

How do I buy shares of CVS Health?

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CVS Health's stock price today?

One share of CVS stock can currently be purchased for approximately $99.38.

How much money does CVS Health make?

CVS Health has a market capitalization of $130.32 billion and generates $292.11 billion in revenue each year. The pharmacy operator earns $7.91 billion in net income (profit) each year or $6.019990 on an earnings per share basis.

How many employees does CVS Health have?

CVS Health employs 300,000 workers across the globe.

Does CVS Health have any subsidiaries?

The following companies are subsidiares of CVS Health: Aetna, Arbor Drugs, Coram Specialty Infusion, EntrustRX, Generation Health L.L.C., IlliniCare Health, Longs Drug Stores, MinuteClinic, Navarro Discount Pharmacy, Omnicare, RxAmerica, Soma Intimates, Stadtlander Drug Company, Stadtlander Pharmacy, TargetPharmacy, and Universal American - Medicare Part D Business.

When was CVS Health founded?

CVS Health was founded in 1963.

What is CVS Health's official website?

The official website for CVS Health is www.cvshealth.com.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at (401) 765-1500, via email at [email protected], or via fax at 401-762-2137.

This page was last updated on 5/18/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.